Transforming Growth Factor Beta Receptor 3 Haplotypes in Sickle Cell Disease Are Associated with Lipid Profile and Clinical Manifestations
Individuals with sickle cell disease (SCD) present both chronic and acute inflammatory events. The TGF-β pathway is known to play a role in immune response, angiogenesis, inflammation, hematopoiesis, vascular inflammation, and cell proliferation. Polymorphisms in the transforming growth factor-beta...
Guardado en:
Autores principales: | Rayra P. Santiago (Autor), Camylla V. B. Figueiredo (Autor), Luciana M. Fiuza (Autor), Sètondji C. M. A. Yahouédéhou (Autor), Rodrigo M. Oliveira (Autor), Milena M. Aleluia (Autor), Suellen P. Carvalho (Autor), Cleverson A. Fonseca (Autor), Valma M. L. Nascimento (Autor), Larissa C. Rocha (Autor), Caroline C. Guarda (Autor), Marilda S. Gonçalves (Autor) |
---|---|
Formato: | Libro |
Publicado: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Associations between TGF-β1 Levels and Markers of Hemolysis, Inflammation, and Tissue Remodeling in Pediatric Sickle Cell Patients
por: Rayra P. Santiago, et al.
Publicado: (2021) -
Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response
por: Sètondji Cocou Modeste Alexandre Yahouédéhou, et al.
Publicado: (2020) -
Absence of atypical haplotype and presence of Senegal haplotype sickle cell disease in African-descent population in the northern Brazil
por: Rafael E. Nascimento, et al.
Publicado: (2015) -
The frequency of βS-globin haplotypes in the state of Paraná, Brazil, and clinical manifestations of sickle cell anemia
por: Alexandra M. Watanabe, et al. -
Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review
por: Joelma Santana dos Santos Neres, et al.
Publicado: (2023)